• Explore /
  • Poster
  • / A phase 1 open label trial of intravenous administration of MVA-BN-Brachyury vaccine in patients with advanced cancer.

A phase 1 open label trial of intravenous administration of MVA-BN-Brachyury vaccine in patients with advanced cancer.

Abstract Video & Slides Poster

Authors

Peter DeMaria

Peter Joseph DeMaria

Genitourinary Malignancy Branch, NCI, NIH, Bethesda, MD

Peter Joseph DeMaria , Katherine Lee-Wisdom , Ravi Amrit Madan , Fatima Karzai , Renee Nicole Donahue , Claudia Palena , Caroline Jochems , Charalampos S. Floudas , Julius Strauss , Jennifer L. Marte , Jason Redman , Houssein Abdul Sater , Borys Korchin , Tatiana Adams , Guenter Silbernagl , Cesar Pico-Navarro , Jeffrey Schlom , James L. Gulley , Marijo Bilusic

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Vaccines

Clinical Trial Registration Number

NCT04134312

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 2617)

DOI

10.1200/JCO.2021.39.15_suppl.2617

Abstract #

2617

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Andrew Mark Haydon

First Author: Andrae L. Vandross

First Author: Iwona A. Lugowska

First Author: Funda Meric-Bernstam